House and Senate Appropriators Pledge to Increase Biomedical Research Funding.
Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center
Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment
Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests
Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High
Funding Opportunities: NCI Offers Grant Supplements
Foon To Direct Barrett Center; Hundahl Leads Commission
National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials
Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System
Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says
Approvals and Applications: European Committee Signs Off On Paxene for KS reatment
Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms
Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol
Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help
